Levetiracetam
Product Images NDC 71093-126

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 71093-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aci Healthcare Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1000-mg (1000 mg)

1000-mg (1000 mg)
Levetiracetam Tablets, USP 1000 mg bottle label by ACI Healthcare USA, Inc. The label specifies a 60-tablet count with directions for dosage, storage, and pharmacist dispensing instructions. The label also includes manufacturer information for ACI HealthCare Limited, Bangladesh, and distributor details for ACI Healthcare USA, Inc., Coral Springs, FL.*
FDA Label Image

250-mg (250 mg)

250-mg (250 mg)
Levetiracetam Tablets, USP, 250 mg, packaged in a container of 120 tablets. The label features a green and purple design and includes storage, dosage, and pharmacist dispensing instructions. Distributed by ACI Healthcare USA, Inc., with manufacturing by ACI HealthCare Limited in Narayanganj, Bangladesh. The label shows a barcode and storage temperature guidelines.*
FDA Label Image

500-mg (500 mg)

500-mg (500 mg)
Levetiracetam Tablets, USP 500 mg bottle label showing 120 tablets. The label indicates storage instructions, pharmacist dispensing requirements, and manufacturer information as ACI Healthcare Limited, Narayanganj, Bangladesh. Distributed by ACI Healthcare USA, Inc. in Coral Springs, FL. Includes barcode and batch details space.*
FDA Label Image

750-mg (750 mg)

750-mg (750 mg)
Levetiracetam 750 mg Tablets, USP packaging label from ACI Healthcare USA, Inc. Contains 120 tablets. Label includes dosage recommendations, storage instructions, pharmacist dispensing information, and manufacturer details listing ACI Healthcare Limited, Narayanganj, Bangladesh. Distributed by ACI Healthcare USA, Inc., Coral Springs, FL.*
FDA Label Image

Fig-1 (Fig 1)

Fig-1 (Fig 1)
A vertical bar graph comparing the percentage of patients among three groups: Placebo (7.4%, N=95), Levetiracetam 1000 mg/day (37.1%, N=97), and Levetiracetam 3000 mg/day (39.6%, N=101). The y-axis represents the percentage of patients from 0% to 45%.*
FDA Label Image

Fig-2 (Fig 2)

Fig-2 (Fig 2)
A bar chart depicting the percentage of patients across three groups: Placebo (N=111) at 6.3%, Levetiracetam 1000 mg/day (N=106) at 20.8%, and Levetiracetam 2000 mg/day (N=105) at 35.2%. The y-axis shows percentage of patients from 0% to 45%.*
FDA Label Image

Fig-3 (Fig 3)

Fig-3 (Fig 3)
Bar chart comparing the percentage of patients between placebo group (14.4%, N=104) and Levetiracetam 3000 mg/day group (39.4%, N=180). The y-axis represents the percentage of patients ranging from 0% to 45%. The Levetiracetam bar is noticeably higher than the placebo bar.*
FDA Label Image

Fig-4 (Fig 4)

Fig-4 (Fig 4)
A bar chart comparing the percentage of patients between Placebo (N=97) and Levetiracetam (N=101). The chart shows 19.6% of patients in the Placebo group and 44.6% in the Levetiracetam group, indicating the distribution of patient response or outcome measured in percentage.*
FDA Label Image

Fig-5 (Fig 5)

Fig-5 (Fig 5)
A vertical bar graph comparing the percentage of patients between two groups: Placebo (N=51) and Levetiracetam (N=58). The y-axis represents the percentage of patients, with the Placebo group showing 19.6% and the Levetiracetam group showing 43.1%. An asterisk is present above the bar for the Levetiracetam group.*
FDA Label Image

Fig-6 (Fig 6)

Fig-6 (Fig 6)
Bar graph comparing the percentage of patients between two groups: Placebo (N=84) with 45.2% and Levetiracetam (N=79) with 72.2%. The y-axis represents the percentage of patients from 0% to 100%.*
FDA Label Image

Levestructure (Levestructure)

Levestructure (Levestructure)
Chemical structure of levetiracetam showing its molecular arrangement with labeled atoms and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.